Michelle Dawson posts

Post published on Twitter/X on 8 Jul 2020 23:31

Back to posts Previous post Next post
Twitter/X DOI work crossref Extract quoted in the post External link integrated into the post Autism terms
Open original post

1 integrated reply by Michelle Dawson

8 Jul 2020 23:33

Note: there are COIs, including "Drs. Wink and Erickson are inventors on a patent describing use of ketamine in autism"

View reply on Twitter/X

Information about the link integrated into the post

DOI work

Logan K. Wink, Debra L. Reisinger, Paul Horn, Rebecca C. Shaffer, Kaela O’Brien, Lauren Schmitt, Kelli R. Dominick, Ernest V. Pedapati, et al. (2021). Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder—Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Journal of Autism and Developmental Disorders, 51(4), 1392-1399. Springer Science and Business Media LLC.

More information

Structured cited links

1 cited resource

DOI work Fetched Post crossref

Logan K. Wink, Debra L. Reisinger, Paul Horn, Rebecca C. Shaffer, Kaela O’Brien, Lauren Schmitt, Kelli R. Dominick, Ernest V. Pedapati, et al. (2021). Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder—Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Journal of Autism and Developmental Disorders, 51(4), 1392-1399. Springer Science and Business Media LLC.

Publication date
8 Jul 2020
Identifier
10.1007/s10803-020-04542-z
Authors
Logan K. Wink, Debra L. Reisinger, Paul Horn, Rebecca C. Shaffer, Kaela O’Brien, Lauren Schmitt, Kelli R. Dominick, Ernest V. Pedapati, Craig A. Erickson
Source
Journal of Autism and Developmental Disorders
Details
51(4), 1392-1399
Reference type
article
Publisher
Springer Science and Business Media LLC
Metadata source
crossref

Abstract

No abstract is available in the recovered metadata.

Study authors in this cited reference

Open DOI Link to cited source